poisar

Stock

Cabaletta Bio, Inc. CABA

$2.73+0.74%

Overview

CABA market data

Price History

CABA price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$2.10
Diluted earnings per share over the trailing twelve months.
Beta
3.44
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.26 – $4.23
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $442.7M · P/B 1.88.

Company News

4 captured
Wells Fargo Maintains Equal-Weight on Cabaletta Bio, Lowers Price Target to $3Benzinga · Aug 14, 2026, 2:46 PM
Cabaletta Bio Q2 EPS $(0.34) Beats $(0.39) EstimateBenzinga · Aug 13, 2026, 11:34 AM
8-K filing — Cabaletta Bio, Inc. (CABA)SEC EDGAR · Aug 13, 2026, 11:32 AM
Wells Fargo Maintains Equal-Weight on Cabaletta Bio, Raises Price Target to $4Benzinga · May 15, 2026, 1:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock